ISLETREGEN Trademark
Trademark Overview
On Thursday, May 23, 2024, a trademark application was filed for ISLETREGEN with the United States Patent and Trademark Office. The USPTO has given the ISLETREGEN trademark a serial number of 98566071. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Tuesday, December 24, 2024. This trademark is owned by IsletRegen, LLC. The ISLETREGEN trademark is filed in the Computer & Software Services & Scientific Services category with the following description:
Research and development of drugs and medicines for the treatment of diabetes, autoimmune thyroiditis, polyneuropathy, autoimmune biliary diseases and poly autoimmunity, degenerative diseases, and other diseases requiring both cellular regenerative activity and suppression of autoimmunity; Research and development in the pharmaceutical, life sciences, and biomedicine fields; Scientific research, testing, and analysis in the fields of pharmaceuticals, life science, and biomedicine; Medical and scientific research on diabetes, autoimmune thyroiditis, polyneuropathy, autoimmune biliary diseases and poly autoimmunity, degenerative diseases and other diseases requiring both cellular regenerative activity and suppression of autoimmunity; Pharmaceutical products testing, analysis, research, and development
General Information
| Serial Number | 98566071 |
| Word Mark | ISLETREGEN |
| Filing Date | Thursday, May 23, 2024 |
| Status | 681 - PUBLICATION/ISSUE REVIEW COMPLETE |
| Status Date | Tuesday, December 24, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, January 14, 2025 |
Trademark Statements
| Goods and Services | Research and development of drugs and medicines for the treatment of diabetes, autoimmune thyroiditis, polyneuropathy, autoimmune biliary diseases and poly autoimmunity, degenerative diseases, and other diseases requiring both cellular regenerative activity and suppression of autoimmunity; Research and development in the pharmaceutical, life sciences, and biomedicine fields; Scientific research, testing, and analysis in the fields of pharmaceuticals, life science, and biomedicine; Medical and scientific research on diabetes, autoimmune thyroiditis, polyneuropathy, autoimmune biliary diseases and poly autoimmunity, degenerative diseases and other diseases requiring both cellular regenerative activity and suppression of autoimmunity; Pharmaceutical products testing, analysis, research, and development |
Classification Information
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, May 23, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | IsletRegen, LLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Charlottesville, VA 22903 |
Trademark Events
| Event Date | Event Description |
| Thursday, May 23, 2024 | NEW APPLICATION ENTERED |
| Sunday, December 1, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Sunday, December 8, 2024 | ASSIGNED TO EXAMINER |
| Tuesday, December 17, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
